No results for ‘’
Senores Pharmaceuticals Ltd
NSE: SENORES BSE: 544319
₹1290
(11.14%)
Wed, 24 Jun 2026, 04:08 am
Market Cap (in Cr)5946.67
PE Ratio49.33
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSenores Pharmaceuticals Balance Sheet
| Particulars | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Interest expense on debt | -5.50M | -20.87M | -94.00M | -215.20M |
| Pretax equity in earnings | 0 | 0 | 0 | 0 |
| Equity in earnings | 0 | 0 | 0 | 0 |
| Total assets | 594.63M | 1.31B | 6.45B | 12.46B |
| Total current assets | 270.52M | 513.37M | 2.51B | 7.22B |
| Cash and short term investments | 32.15M | 1.00M | 130.60M | 3.85B |
| Cash & equivalents | 32.15M | 1.00M | 78.50M | 1.05B |
| Short term investments | 0 | 0 | 52.10M | 2.80B |
| Total receivables, net | 196.31M | 389.77M | 1.80B | 2.42B |
| Accounts receivable - trade, net | 196.31M | 383.77M | 1.78B | 2.41B |
| Other receivables | 0 | 6.00M | 16.20M | 11.50M |
| Total inventory | 31.64M | 87.03M | 407.20M | 594.90M |
| Other current assets, total | 10.28M | 23.55M | 144.10M | 283.30M |
| Total non-current assets | 324.11M | 797.16M | 3.94B | 5.24B |
| Long term investments | 165.84M | 169.52M | 194.90M | 39.00M |
| Note receivable - long term | 10.36M | 980.00K | 0 | 25.70M |
| Investments in unconsolidated subsidiaries | 0 | 0 | 0 | 0 |
| Other investments | 155.48M | 168.54M | 194.90M | 13.30M |
| Net property/plant/equipment | 61.16M | 161.99M | 1.82B | 2.60B |
| Gross property/plant/equipment | 61.40M | 162.83M | 1.89B | 2.79B |
| Deferred tax assets | 7.62M | 0 | 377.60M | 377.50M |
| Net intangible assets | 88.42M | 464.43M | 1.53B | 2.21B |
| Goodwill, net | 0 | 0 | 382.10M | 382.10M |
| Other intangibles, net | 88.42M | 464.43M | 1.15B | 1.83B |
| Other long term assets, total | 1.07M | 1.22M | 9.60M | 12.90M |
| Short term debt | 21.32M | 312.79M | 1.16B | 1.44B |
| Current portion of LT debt and capital leases | 1.41M | 231.22M | 838.20M | 1.13B |
| Short term debt excl. current portion of LT debt | 19.91M | 81.57M | 323.90M | 312.10M |
| Accounts payable | 71.36M | 135.82M | 1.13B | 672.20M |
| Income tax payable | 1.28M | 15.85M | 71.10M | 134.90M |
| Long term debt | 126.23M | 313.15M | 1.41B | 1.71B |
| Long term debt excl. lease liabilities | 126.23M | 313.15M | 1.41B | 1.71B |
| Total equity | 365.90M | 454.99M | 2.32B | 8.12B |
| Shareholders' equity | 365.90M | 454.99M | 2.04B | 7.86B |
| Common equity, total | 365.90M | 454.99M | 2.04B | 7.86B |
| Other common equity | 25.99M | 3.93M | -20.50M | -48.40M |
| Total debt | 147.55M | 625.94M | 2.58B | 3.15B |
| Net debt | 115.40M | 624.94M | 2.45B | -707.50M |
| Change in accounts receivable | -152.10M | -15.36M | -571.10M | -118.80M |
| Change in taxes payable | — | — | — | — |
| Change in accounts payable | 70.07M | 64.46M | 509.00M | -457.90M |
| Change in other assets/liabilities | -16.87M | -193.78M | -587.90M | -575.00M |
| Sale of fixed assets & businesses | 25.40M | 0 | 0 | 0 |
| Purchase/sale of investments, net | -139.52M | -10.49M | 0 | -2.76B |
| Sale/maturity of investments | 0 | 0 | 0 | — |
| Purchase of investments | -139.52M | -10.49M | 0 | -2.76B |
| Other investing cash flow items, total | 0 | 0 | 4.30M | 3.30M |
| Issuance/retirement of debt, net | 104.99M | 465.86M | 612.20M | 1.21B |
| Issuance/retirement of long term debt | 89.93M | 175.46M | 31.70M | 288.10M |
| Issuance/retirement of short term debt | 15.06M | 290.40M | 580.50M | 922.00M |
| Issuance/retirement of other debt | — | — | — | — |
| Total cash dividends paid | 0 | 0 | 0 | 0 |
| Other financing cash flow items, total | 0 | 0 | 0 | 0 |